Data

• Supplementary material for KRAS-targeting drug combinations in NSCLC manuscript
• Supplementary material for CANDOCK HIV-1 protease inhibitor manuscript
• Supplementary material for CANDO performance evaluation manuscript
• Supplementary material for CANDO multiscale optimization manuscript
• Supplementary material for CANDO COVID-19 drug candidate discovery manuscript
• Supplementary material for CANDO network interactomics drug discovery manuscript
• Supplementary material for RNAsee biodiversity manuscript
• Supplementary material for the CANDO benchmarking protocol manuscript
• Supplementary material for the CANDO glioma manuscript